Allworth Financial’s AbbVie ABBV Stock Holding History

Allworth Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.4M	Sell	263,766 -440	-0.2%	-$97.6K	0.23%	66
2025 Q4	$60.4M	Buy	264,206 +20,372	+8%	+$4.64M	0.25%	59
2025 Q3	$56.5M	Buy	243,834 +30,124	+14%	+$6.13M	0.25%	59
2025 Q2	$39.7M	Buy	213,710 +64,685	+43%	+$12M	0.19%	71
2025 Q1	$26.9M	Buy	149,025 +5,006	+3%	+$973K	0.15%	85
2024 Q4	$24.4M	Buy	144,019 +57,468	+66%	+$10.6M	0.13%	92
2024 Q3	$17.1M	Buy	86,551 +38,273	+79%	+$7.14M	0.1%	109
2024 Q2	$8.32M	Buy	48,278 +11,439	+31%	+$1.89M	0.05%	151
2024 Q1	$6.71M	Buy	36,839 +6,619	+22%	+$1.14M	0.05%	155
2023 Q4	$4.68M	Buy	30,220 +1,285	+4%	+$187K	0.04%	191
2023 Q3	$4.31M	Buy	28,935 +3,768	+15%	+$553K	0.04%	183
2023 Q2	$3.39M	Sell	25,167 -1,367	-5%	-$200K	0.03%	216
2023 Q1	$4.23M	Buy	+26,534	New	+$4.06M	0.04%	173
2022 Q4	–	Sell	-20,417	Closed	-$2.74M	–	2981
2022 Q3	$2.74M	Buy	20,417 +2,387	+13%	+$343K	0.03%	194
2022 Q2	$2.76M	Buy	18,030 +1,088	+6%	+$166K	0.04%	186
2022 Q1	$2.75M	Buy	16,942 +8,538	+102%	+$1.24M	0.04%	187
2021 Q4	$1.14M	Buy	8,404 +1,067	+15%	+$126K	0.02%	268
2021 Q3	$791K	Buy	7,337 +1,341	+22%	+$153K	0.01%	263
2021 Q2	$675K	Sell	5,996 -4,373	-42%	-$493K	0.01%	226
2021 Q1	$1.12M	Buy	10,369 +412	+4%	+$44.1K	0.02%	155
2020 Q4	$1.07M	Sell	9,957 -126	-1%	-$12.1K	0.03%	115
2020 Q3	$883K	Sell	10,083 -236	-2%	-$22.2K	0.03%	107
2020 Q2	$1.01M	Buy	10,319 +734	+8%	+$64.6K	0.03%	91
2020 Q1	$730K	Buy	9,585 +193	+2%	+$16.4K	0.02%	128
2019 Q4	$832K	Buy	9,392 +978	+12%	+$81.2K	0.03%	81
2019 Q3	$637K	Buy	8,414 +2,786	+50%	+$191K	0.02%	80
2019 Q2	$409K	Sell	5,628 -366	-6%	-$28.8K	0.02%	105
2019 Q1	$483K	Buy	5,994 +381	+7%	+$31.2K	0.02%	93
2018 Q4	$517K	Buy	5,613 +594	+12%	+$52.2K	0.03%	87
2018 Q3	$475K	Sell	5,019 -29	-0.6%	-$2.75K	0.02%	95
2018 Q2	$468K	Buy	5,048 +1,158	+30%	+$113K	0.02%	95
2018 Q1	$368K	Buy	3,890 +47	+1%	+$5.16K	0.03%	83
2017 Q4	$372K	Sell	3,843 -194	-5%	-$18.3K	0.03%	79
2017 Q3	$359K	Buy	4,037 +69	+2%	+$5.25K	0.03%	78
2017 Q2	$288K	Buy	3,968 +190	+5%	+$12.8K	0.03%	84
2017 Q1	$246K	Sell	3,778 -501	-12%	-$31.5K	0.02%	88
2016 Q4	$268K	Buy	4,279 +1,310	+44%	+$80K	0.03%	82
2016 Q3	$187K	Buy	2,969 +139	+5%	+$9K	0.02%	103
2016 Q2	$175K	Hold	2,830	–	–	0.02%	105
2016 Q1	$162K	Sell	2,830 -40	-1%	-$2.23K	0.02%	111
2015 Q4	$170K	Buy	2,870 +600	+26%	+$34.6K	0.03%	102
2015 Q3	$123K	Buy	2,270 +204	+10%	+$13.3K	0.04%	114
2015 Q2	$139K	Hold	2,066	–	–	0.05%	115
2015 Q1	$121K	Buy	+2,066	New	+$125K	0.05%	123

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Allworth Financial's ABBV Position: Q1 2026 in Review

Allworth Financial reduced its AbbVie (ABBV) stake by 0.17% in Q1 2026, selling an estimated $97.6K and leaving 263,766 shares worth $57.4M. The position accounts for 0.23% of the portfolio, ranked #66.

Allworth Financial first reported a position in ABBV in Q1 2015 and has held it in 44 quarters since. The position peaked at $60.4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Allworth Financial held 263,766 shares of AbbVie worth $57.4M as of Q1 2026.
Allworth Financial sold 440 AbbVie shares in Q1 2026, an estimated $97.6K.
AbbVie made up 0.23% of Allworth Financial's portfolio in Q1 2026, its #66 holding.
Allworth Financial first reported a position in AbbVie in Q1 2015 and has held it in 44 quarters since.
Allworth Financial's AbbVie position peaked at $60.4M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.